Non-human animals expressing pH-sensitive immunoglobulin sequences
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsJohn McWhirter, Lynn Macdonald, Joel H. Martin, Andrew J. Murphy
Life of this patent
Estimating the term…
Loading patent…
AssigneeRegeneron Pharmaceuticals, Inc.
InventorsJohn McWhirter, Lynn Macdonald, Joel H. Martin, Andrew J. Murphy
Estimating the term…
Genetically modified non-human animals are provided that express an immunoglobulin variable domain that comprises at least one histidine, wherein the at least one histidine is encoded by a substitution of a non-histidine codon in the germline of the animal with a hisidine codon, or the insertion of a histidine codon in a germline immunoglobulin nucleic acid sequence. Immunoglobulin genes comprising histidines in one or more CDRs, in an N-terminal region, and or in a loop 4 region are also provided. Immunoglobulin variable domains comprising one or more histidines (e.g., histidine clusters) substituted for non-antigen-binding non-histidine residues. Non-human animals that are progeny of animals comprising modified heavy chain variable loci (V, D, J segments), modified light chain variable loci (V, J segments), and rearranged germline light chain genes (VJ sequences) are also provided. Non-human animals that make immunoglobulin domains that bind antigens in a pH-sensitive manner are provided.
A genetically modified non-human animal comprising in its germline an endogenous immunoglobulin locus that comprises an unrearranged immunoglobulin variable gene sequence comprising in a complementarity determining region 3 (CDR3) encoding sequence a substitution of at least one non-histidine codon with a histidine codon or an insertion of at least one histidine codon,
A genetically modified non-human animal, comprising
A genetically modified non-human animal, comprising
Dependencies are inferred from the claim text.